Business · 16/06/20261 min read

FDA Corrects Withdrawal of 11 Abbreviated New Drug Applications

The US Food and Drug Administration (FDA) is correcting a notice that announced the withdrawal of approval of 11 abbreviated new drug applications (ANDAs) from multiple applicants, including Masuu Global Solutions LLC, U.S. Agent for Extrovis AG. The corrections rectify an error where the approvals of these ANDAs were mistakenly withdrawn.